Enliven Therapeutics Inc Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 1,000 @ $25.38 | $25.38 K | 0 | 11/27/2024 | 12/02/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 4,250 @ $24.78 | $105.31 K | 1,000 | 11/27/2024 | 12/02/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 650 @ $29.11 | $18.92 K | 0 | 10/28/2024 | 10/30/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 5,600 @ $28.49 | $159.56 K | 650 | 10/28/2024 | 10/30/2024 | |
|
Heyman Richard A.
Director |
Sell | 753 @ $30.00 | $22.59 K | 27,165 | 10/18/2024 | 10/22/2024 | |
|
Kintz Samuel
CEO |
Sell | 924 @ $30.00 | $27.72 K | 1,002,892 | 10/18/2024 | 10/22/2024 | |
|
Patel Anish
CHIEF OPERATING OFFICER |
Sell | 716 @ $30.00 | $21.48 K | 343,311 | 10/18/2024 | 10/22/2024 | |
|
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER |
Sell | 847 @ $30.00 | $25.41 K | 1,015,188 | 10/18/2024 | 10/22/2024 | |
|
Collins Helen Louise
CHIEF MEDICAL OFFICER |
Sell | 816 @ $30.00 | $24.48 K | 0 | 10/18/2024 | 10/22/2024 | |
|
Heyman Richard A.
Director |
Sell | 817 @ $30.00 | $24.51 K | 123,673 | 10/18/2024 | 10/22/2024 | |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER |
Sell | 814 @ $30.00 | $24.42 K | 0 | 10/18/2024 | 10/22/2024 | |
|
Heyman Richard A.
Director |
Sell | 1,270 @ $27.67 | $35.14 K | 124,490 | 10/15/2024 | 10/17/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
No record found